Background-A comprehensive evaluation of myocardial ischemia requires measures of both oxygen supply and demand.
A dequate oxygenation is fundamental to myocardial health. The balance of oxygen supply (myocardial blood flow [MBF] ) and oxygen demand (myocardial oxygen consumption [MVO 2 ]) is the central pathological tenet of myocardial ischemia. Conversely, luxuriant MVO 2 compared with level of cardiac work is indicative of reduced cardiac efficiency, a common finding in most forms of heart failure. 1 Therefore, accurate measurements of the key components of myocardial oxygenation, including MBF, MVO 2 , and fractional oxygen extraction (OEF), are needed to better understand the pathophysiology of these various disease processes. This knowledge may lead to new diagnostic strategies and could facilitate the evaluation of therapies designed to improve oxygen supply/demand imbalances or improve energy transduction.
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To date, positron emission tomography (PET) has been used to provide these measurements, with 15 O-water to measure MBF 2 and 11 C-acetate to determine MVO 2 . 3 However, ionizing radiation, long scan times, limited availability, requirement of an on-site cyclotron, and high costs have limited the widespread use of PET for these purposes. Because of the physical half-life of the radiotracers and concerns about radiation exposure, measurements are typically limited to only 2 time points, such as rest and low-level catecholamine stress. Additionally, PET cannot assess myocardial blood volume (MBV), another important parameter of myocardial oxygen supply. 4 In contrast, MRI does not use ionizing radiation, requires relatively short scan times, is more readily available and at lower cost, and is relatively fast and reproducible. Thus, it is optimal for serial assessments of myocardial oxygenation. We have developed a variety of MRI techniques for evaluating MBF, 5,6 MBV, 7 OEF, 8 -9 and MVO 2 10 through a combination of first-pass perfusion and blood oxygen leveldependent (BOLD) methods. In this study, we used these techniques to evaluate the regional changes in myocardial perfusion and oxygenation induced by an acute coronary artery stenosis at rest and during pharmacological hyperemia. The MRI measurements were validated against those obtained by PET imaging. Dipyridamole and dobutamine were used in dogs with or without moderate to severe coronary artery stenosis to induce a wide range of myocardial perfusion and oxygenation changes.
Methods

Study Protocol
All animal protocols were approved by the Animal Studies Committee at Washington University. The study was performed in 21 beagle and small mongrel dogs (average weight, 9.4Ϯ1.9 kg), divided into 5 groups, as shown in the Table. The study protocol is shown in Figure 1 . Pharmacological stress was performed with intravenous dipyridamole (Bedford Laboratories, Bedford, Ohio) or intravenous dobutamine (Abbott Labs, Chicago, Ill). Dipyridamole was infused at a rate of 0.14 mg ⅐ min Ϫ1 ⅐ kg Ϫ1 body wt for 4 minutes. Dobutamine was started at a dose of 5 g ⅐ min Ϫ1 ⅐ kg Ϫ1 body wt and titrated at 5 g ⅐ min Ϫ1 ⅐ kg Ϫ1 intervals every 3 minutes until the rate-pressure product was approximately doubled compared with rest (maximum dose, 30 g ⅐ min Ϫ1 ⅐ kg Ϫ1 body wt). Dobutamine doses were typically the same during MR and PET scans but were occasionally optimized to retain similar hemodynamic states between the 2 imaging modalities; the average dobutamine dose was 20 g ⅐ min Ϫ1 ⅐ kg Ϫ1 during both MR and PET scans.
Animal Preparation and Surgery
Dogs were anesthetized with intravenous sodium thiopental (12.5 mg ⅐ kg Ϫ1 ), intubated with an endotracheal tube, and then ventilated with 100% oxygen at a tidal volume of 12 mL ⅐ kg Ϫ1 at a rate of 15 to 20 breaths/min. The animals were monitored continuously and anesthesia was maintained with ventilated 1% to 2% isoflurane.
Bilateral femoral arterial and venous cut-downs were performed and an arterial catheter was connected to a fluid-filled transducer for blood pressure monitoring. Another catheter was placed in a femoral vein for the administration of fluids and dipyridamole or dobutamine.
The procedures for setting the coronary artery stenosis clamp were described previously. 11 Briefly, a thoracotomy was performed in the fourth left intercostal space and the pericardium was incised. The left anterior descending coronary artery (LAD) was dissected free distal to the first diagonal branch, and small arterial branches were ligated to provide a 1-to 2-cm length for instrumentation. The artery was instrumented with, in a proximal-distal order, a Doppler flow probe, a pneumatic occluder, and a homemade MR-compatible stenosis clamp. Serial 20-second occlusions were performed to determine the hyperemic flow response. After the stenosis clamp was tightened, another occlusion was performed to assess the decrease in the hyperemic flow response. After attaining the desired level of stenosis defined by reduction in hyperemic flow, 11 the occluder and Doppler probe were removed, leaving only the MR-compatible stenosis clamp on the artery. Group 4 dogs with moderate stenosis had approximately 75% reduction in the cross-sectional area of the LAD. The 2 "severe" stenosis groups (groups 2 and 5) had 95% to 100% LAD reduction in cross-sectional area of the LAD.
After the stenosis severity was set, the dogs' chests were closed and evacuated. Control dogs did not undergo thoracotomy surgery. The dogs were then secured onto a plastic bed in the supine position to immobilize the body during transport between the surgical, MRI, and PET imaging suites. PET imaging always occurred after MRI as radiation safety measures do not allow "hot" animals to enter the MRI suite. After PET imaging, the animals were euthanized while still under anesthesia with an overdose of potassium chloride to arrest the heart.
MRI Methods
MRI was performed on a 1.5-T Sonata scanner (Siemens Medical Solutions, Erlanger, Germany). A 4-element, phased-array coil placed around the chest was used for signal reception, and a body coil was used as a transmitter. Scout imaging was performed to obtain a short-axis image of the left ventricle (LV) at the midcavity level. Cine imaging was performed to determine the motionless period of the cardiac cycle. During all MR scans, respiratory motion was eliminated by turning off ventilation at the end of expiration to simulate breath-holding.
MR First-Pass Perfusion Imaging
Images during the bolus injection of 15 mol/kg Gadomer (Bayer Schering Pharma AG, Berlin, Germany), an intravascular contrast agent, were sequestered by a saturation-prepared turbo fast lowangle shot sequence, as described previously. 5 The short-axis slice of the LV was acquired during mid-diastole; triggered by the R-wave of the ECG. Sixty to 80 dynamic images were gathered sequentially in the motionless period of mid-diastole of every R-R interval (typically Ϸ400 ms after the R-wave). Other imaging parameters included repetition time, 2.5 ms; echo time, 1.2 ms; inversion time, 90 ms; flip angle, 18°; field of view, 220ϫ138 mm 2 ; matrix size, 128ϫ80%; slice thickness, 8 mm; bandwidth, 675 Hz per pixel; and image acquisition time window per cardiac cycle, 150 ms.
Gadomer is a synthetic, paramagnetic complex with 24 chelated Gd ions bonded to a dendritic backbone. 12 The macromolecular contrast agent (30 to 35 kDa) is almost exclusively intravascular and has fast renal retention; therefore, it has rapid clearance (half-lifeϭ11 minutes in dogs). 12 The R 1 relaxivity is Ϸ13 mmol/L Ϫ1 /s Ϫ1 , which is 3-fold higher than extravascular contrast agents at 1.5 T. 13 Therefore, Gadomer is the optimal contrast agent for use in this study to allow for rapid clearance before BOLD imaging during pharmacological stress.
MR Oxygenation Imaging
Imaging of myocardial oxygenation was performed with a BOLD sequence that measures myocardial T 2 signals as described previously. 8, 9 The imaging sequence for this technique was a multicon- 
PET Methods
PET imaging was performed on a Focus 220 microPET scanner (Concorde Medical Systems, Knoxville, Tenn). A transmission scan was first performed with a rod source to ensure proper positioning and to correct for photon attenuation. 15 O-water (average, 7.5Ϯ1.8 mCi) was administered intravenously, and dynamic PET data were acquired for 5 minutes. After 10 minutes, which allowed for decay of the 15 O-water, 11 C-acetate (average 7.8Ϯ2.4 mCi) was injected intravenously and dynamic PET data were collected for 30 minutes. Approximately 40 minutes after the resting 11 C-acetate scan (to allow for radionuclide decay), the pharmacological stressor was started, set to the appropriate dose to approximately match the hemodynamics during MRI, and the 15 O-water and 11 C-acetate protocols were repeated for stress imaging.
Image Analysis
MRI Analysis
First-pass perfusion images were first analyzed by a nonblinded reviewer with a JAVA program (Java V5.0, Sun Microsystems, Santa Clara, Calif) developed in our laboratory. 5 Images were de-noised by a wavelet method 14 and analyzed by a new model-independent perfusion algorithm validated in our laboratory. 5 This algorithm rapidly generated both MBF and MBV maps, on which regions of interest (ROIs) could be drawn. For ease of representation, the fully regional data were averaged in 4 segments: LAD-perfused anterior, lateral, remote inferior, and septal myocardial regions. The anterior segment represents perfusion-defected myocardial tissue in stenotic dogs (Figure 2 ). BOLD T 2 -weighted images were analyzed with a MATLAB graphics program (MathWorks, Natick, Mass). Pixel-by-pixel maps of the myocardial T 2 decay constants were calculated from the T 2 -weighted signal intensities. Then OEF maps during hyperemia were determined with our previously described model, 8, 9 on which ROIs similar to the first-pass perfusion map ROIs were drawn. The 2 T 2 maps with different echo spacings at rest were used to determine model parameters for the calculation of OEF during hyperemia. MBV values both at rest and stress, which are required inputs for the OEF calculation, were determined from the first-pass perfusion images. A resting OEF of 0.6 was assumed, which was based on our previous studies of arterial and coronary sinus blood sampling measurements in control dogs at rest (R 2 ϭ0.90), 8 as well as PET measurements in dogs with moderate stenosis (R 2 ϭ0.75). 10 Resting and hyperemic MVO 2 were then estimated by the Fick law:
The constant [O 2 ] a is defined as the total oxygen content of arterial blood, 15 and a value of 7.99 mol ⅐ mL Ϫ1 was used. All images were analyzed in a fully regional manner with anterior, lateral, inferior, and septal ROIs assessed in the LV.
PET Image Analysis
The nongated, attenuation-corrected images were reconstructed with filtered back-projection and transferred to a Sun workstation (Sun Microsystems). Three image slices that approximately matched the MR slice were selected, and ROIs matching the MR image ROIs were drawn to generate blood and myocardial time-activity curves. MBF was determined by a previously validated compartmental modeling method. 2 MVO 2 was then determined by a 1-compartment kinetic model to estimate the rate at which 11 C-acetate was converted to 11 CO 2 . 3 Regional OEF was then estimated by the Fick law (Equation 1). PET images were analyzed by a second nonblinded reviewer.
Statistical Analysis
Data are reported as meanϮSD. Linear regressions were used to assess the accuracy of the MRI-determined values for MBF, MVO 2 , and OEF measurements compared with those obtained with PET. The correlation data were pooled from data measured on all 4 myocardial segments. Bland-Altman plots were also used, and percentiles of differences (mean difference Ϯ1.96 SD) were calcu-lated. Unpaired t tests were used to determine the significance of differences between MRI and PET measurements. Two-sided probability values Ͻ0.05 were considered statistically significant.
Results
Interventions and Hemodynamics
Surgical preparation of animals took an average of 1.5 hours. Hemodynamics at rest and stress appeared comparable for all dogs between the MR and PET imaging sessions (Figure 3 ). Strong correlation for heart rate was observed with moderate correlation in rate-pressure product, which reflects some physiological variations between PET and MRI scan sessions.
Regional MBF
Representative MRI and PET images from a control dog and a dog with a severe LAD stenosis are shown in Figure 2 . As expected, increased stenosis severity progressively attenuated the MBF increase during pharmacologically induced hyperemia. With myocardial segment-based analysis, the correlation between MR and PET measurements was strong (slope, 0.88; intercept, 0.25; rϭ0.90, PϽ0.001; Figure 4 ). The Bland-Altman plot shows a mean difference of 0.006 mL/g/ min (limits of agreement, Ϫ0.76 to 0.77). There was no systematical error in MRI MBF measurements. . Plots contain regional data from all dogs. MBF plots contain rest and stress data; MVO 2 and OEF plots contain only stress data because of the assumed rest OEF of 0.6 for MRI.
Regional Myocardial Oxygenation (OEF and MVO 2 )
The regional MVO 2 and OEF data included data during pharmacological stress only (Figure 4) , due to the assumed resting OEF of 0.6 for MRI. The regression plot in MVO 2 demonstrated good correlation (slope, 0.83; intercept, 1.41; rϭ0.86, PϽ0.001). Bland-Altman analysis showed a mean difference of 0.42 mol/g/min (limits of agreement, Ϫ3.6 to 4.5). For OEF measurements, moderate correlation was observed for MRI measurements in comparison with PET measurements (slope, 0.7; intercept, 0.14; rϭ0.81, PϽ0.01), although the relatively low slope indicates slightly systematic underestimation. Bland-Altman analysis showed a mean difference of Ϫ0.015 (limits of agreement: Ϫ0.28 to 0.25).
Discussion
This study evaluated several MRI techniques for the assessment of myocardial perfusion and oxygenation compared with PET quantification methods in a canine model of coronary artery stenosis. We found that the MR methods provided reasonable estimates of both oxygen supply and demand. With PET as the gold standard, MBF, OEF, and MVO 2 were quantified and validated with moderate to very good correlations by MRI methods.
The experimental design with various coronary artery stenoses and 2 pharmacological stressors provided a wide range of changes in MBF (0.74 to 4.3 mL/g/min), OEF (0.19 to 0.9), and MVO 2 (2.5 to 20.4 mol/g/min). In general, the vasodilator dipyridamole can increase MBF 3-to 4-fold and can substantially reduce myocardial OEF in normal tissue, but it also produces a minimal effect on MVO 2 . With increasing coronary artery stenosis, the impact of dipyridamole will be less pronounced and reduction of OEF will decline progressively. In contrast, the inotropic agent dobutamine increases MVO 2 by increasing cardiac work load, which in turn increases MBF. Small changes in MVO 2 with the vasodilator dipyridamole were also observed in our study, possibly due to slight systemic hypotension and reflex tachycardia, which have been reported previously. 16 In this study, MBF shows the best correlation between MRI and PET measurements, followed by MVO 2 and OEF measurements. This probably was due to the robust measurement of MBF by our well-established perfusion quantification technique. 5 The variation observed in MVO 2 measurement may be due to measurement errors in MBF and OEF but also may be partially related to hemodynamic differences in the dogs between MRI and PET sessions. Notably, Figure 3 shows a moderate correlation coefficient of rate-pressure product data between the 2 studies (rϭ0.77), which matches well with the moderate correlation of MVO 2 in Figure 4 (rϭ0.86).
Compared with MBF and MVO 2 measurements, OEF showed the greatest dissimilarities between MRI and PET measurements in this study. This probably was due to the assumed resting OEF of 0.6 for MRI, which was determined in an earlier study using arterial and coronary sinus blood gases in control dogs. 8 In this study, OEF in the entire LV wall was 0.64Ϯ0.17, measured by PET. The slightly lower resting OEF value of 0.6 would result in a lower calculated hyperemic OEF as well, which can be seen from the Bland-Altman analysis in Figure 4 , showing that MRI slightly underestimated the hyperemic OEF determined by PET. Again, these differences were not significant, and MR and PET OEF measurements were reasonably well correlated. Additionally, if the MRI hyperemic OEF is calculated using the resting OEF value determined by PET (instead of the assumed 0.6), the calculated MRI hyperemic OEF is not significantly changed (slope, 1.01; intercept, 0.02; rϭ0.81, PϽ0.001; Figure 5 ).
Another issue is the possible interference of the first contrast injection with the pharmacological stress BOLD imaging. As noted, Gadomer has high renal retention and rapid clearance. With a half-life of 11 minutes in dogs 12 as well as the low dosage of Gadomer, a lag time of 60 minutes before starting the stress BOLD imaging was found to be sufficient to minimize the effect of the first contrast injection. Based on the information from the previous report about the pharmacokinetics of Gadomer, 12 it can be estimated that the change in myocardial T 2 value due to the contrast injection at 60 minutes was Ͻ1.1%, which is well within the myocardial T 2 measurement error range (Ϸ3.5%). 8 One limitation of the measurement of perfusion in stenotic dogs is the possible leakage of Gadomer into the extravascular space caused by capillary breakdown. We also performed late enhancement analyses in several dogs in groups 2 and 5, and no significant enhancement was observed at rest or during the pharmacologically induced stress, indicating that no infarction occurred in this animal ischemia model. It should be noted that our perfusion quantification method used a model-free deconvolution, which may be applicable to the extracellular contrast agent as well. Nevertheless, the effect of Gadomer leakage on the accuracy of the perfusion measurement should be investigated systematically in the future. It is also recognized that the PET scan was always performed after the MRI scan due to the availability of the isotopes at the time of the PET scan and radiation safety issues. This experimental design sequence may introduce systematical errors because the physiological states of the dogs, such as resting MBF, may progressively change. Every effort was made to ensure stability of the heart rate and blood pressure of the dogs during and between the MRI and PET scans (Figure 3 ).
Conclusion
MRI quantification methods for myocardial oxygenation are promising alternatives to nuclear techniques because they could be used for serial assessments of perfusion and oxygenation in settings of regional or global myocardial ischemia. This repeatability could allow for dose-response studies necessary for the development of new therapies. In addition, these techniques could easily be coupled with other cardiac MRI methods, such as delayed enhancement and wall-motion analyses, thereby making MRI a valuable "1-stop shop" for imaging regional or global myocardial ischemia.
